Alterity Therapeutics Limited (PRNAF)
OTCMKTS
· Delayed Price · Currency is USD
0.0036
-0.0032 (-47.06%)
At close: Jul 25, 2024
Alterity Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Cash & Equivalents | 12.64 | 12.64 | 15.77 | 34.81 | 28.12 | 9.2 | Upgrade
|
| Cash & Short-Term Investments | 12.64 | 12.64 | 15.77 | 34.81 | 28.12 | 9.2 | Upgrade
|
| Cash Growth | -19.87% | -19.87% | -54.68% | 23.80% | 205.71% | -36.13% | Upgrade
|
| Accounts Receivable | 4.02 | 4.02 | 8.65 | 4.67 | 4.13 | - | Upgrade
|
| Other Receivables | 0.02 | 0.02 | 0.02 | 0.06 | 0.15 | 0.06 | Upgrade
|
| Receivables | 4.04 | 4.04 | 8.67 | 4.73 | 4.28 | 0.06 | Upgrade
|
| Prepaid Expenses | 2.32 | 2.32 | 2.57 | 1.6 | 1.09 | 0.57 | Upgrade
|
| Other Current Assets | 0.04 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Current Assets | 19.04 | 19.04 | 27.05 | 41.14 | 33.49 | 9.84 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.19 | 0.27 | 0.22 | 0.1 | 0.07 | Upgrade
|
| Total Assets | 19.22 | 19.22 | 27.32 | 41.36 | 33.59 | 9.91 | Upgrade
|
| Accounts Payable | 0.58 | 0.58 | 1.72 | 2.66 | 1.45 | 0.95 | Upgrade
|
| Accrued Expenses | 4.56 | 4.56 | 2.5 | 3.02 | 1.56 | 1.72 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.11 | 0.11 | 0.06 | 0.03 | 0.03 | Upgrade
|
| Current Income Taxes Payable | 0.02 | 0.02 | 0.03 | 0.03 | - | - | Upgrade
|
| Other Current Liabilities | 0.11 | 0.11 | 0.03 | 0.06 | 0.03 | 0.01 | Upgrade
|
| Total Current Liabilities | 5.37 | 5.37 | 4.38 | 5.82 | 3.07 | 2.71 | Upgrade
|
| Long-Term Leases | 0.05 | 0.05 | 0.1 | 0.06 | 0.04 | 0 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.02 | 0.01 | 0.01 | 0.04 | Upgrade
|
| Total Liabilities | 5.43 | 5.43 | 4.5 | 5.89 | 3.12 | 2.76 | Upgrade
|
| Common Stock | 223.15 | 223.15 | 213.97 | 213.79 | 197.45 | 160.7 | Upgrade
|
| Retained Earnings | -214.16 | -214.16 | -195.13 | -181.88 | -169.73 | -154.42 | Upgrade
|
| Comprehensive Income & Other | 4.81 | 4.81 | 3.97 | 3.57 | 2.75 | 0.87 | Upgrade
|
| Shareholders' Equity | 13.8 | 13.8 | 22.81 | 35.47 | 30.47 | 7.15 | Upgrade
|
| Total Liabilities & Equity | 19.22 | 19.22 | 27.32 | 41.36 | 33.59 | 9.91 | Upgrade
|
| Total Debt | 0.16 | 0.16 | 0.21 | 0.12 | 0.07 | 0.03 | Upgrade
|
| Net Cash (Debt) | 12.48 | 12.48 | 15.56 | 34.69 | 28.05 | 9.16 | Upgrade
|
| Net Cash Growth | -19.81% | -19.81% | -55.13% | 23.67% | 206.12% | -36.37% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | Upgrade
|
| Filing Date Shares Outstanding | 5,320 | 5,320 | 2,440 | 2,407 | 2,407 | 1,085 | Upgrade
|
| Total Common Shares Outstanding | 5,245 | 5,245 | 2,440 | 2,407 | 2,084 | 1,037 | Upgrade
|
| Working Capital | 13.66 | 13.66 | 22.67 | 35.32 | 30.42 | 7.12 | Upgrade
|
| Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Tangible Book Value | 13.8 | 13.8 | 22.81 | 35.47 | 30.47 | 7.15 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.